Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00220_DB00541_nanopub.RAlwAowyFqT_IMRn-nwSavr5hT_qqVKcANqyVQqFEnVMg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00220_DB00541 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00220_DB00541 label "DDI between Nelfinavir and Vincristine - Nelfinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Nelfinavir is initiated, discontinued or dose changed. [drugbank_resource:DB00220_DB00541]" assertion.
- drugbank_resource:DB00220_DB00541 identifier "drugbank_resource:DB00220_DB00541" assertion.
- drugbank_resource:DB00220_DB00541 title "DDI between Nelfinavir and Vincristine - Nelfinavir, a strong CYP3A4 inhibitor, may increase the serum concentration of Vincristine by decreasing its metabolism. Consider alternate therapy to avoid Vincristine toxicity. Monitor for changes in the therapeutic and adverse effects of Vincristine if Nelfinavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB00541 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00220_DB00541 assertion.
- drugbank:DB00220 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00220_DB00541 assertion.